drugset / Trial / NCT01387594

Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFs

NCT01387594 ↗

Phase 1 Completed 49 enrolled Shire
Non-randomizedSingle-groupOpen-labelBasic science

Summary

Study is designed to show a lack of effect on white blood cells circulating in the spinal fluid.

Timeline

Start
2012-05-03
Primary completion
2014-03-31
Completion
2015-11-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Ontamalimab Monoclonal antibody 225 mg Subcutaneous